<DOC>
	<DOCNO>NCT01532102</DOCNO>
	<brief_summary>The purpose study determine safety , tolerability efficacy topical application AP611074 5 % gel 6 week ano-genital wart cause human papillomavirus ( HPV ) .</brief_summary>
	<brief_title>Safety Efficacy Study Topical AP611074 Gel Treat Genital Warts</brief_title>
	<detailed_description>Genital wart ( GW ; also call condylomas condylomata acuminata ) lesion cause infection Human papillomavirus ( HPV ) ( specifically HPV-6 HPV-11 type , find &gt; 95 % lesion ) . GW sexually transmit affect 1 % sexually active population . GW represent distressful condition social sexual life , especially case external condylomas . No HPV-specific antiviral treatment exists date , exist therapy ( either surgical drug ) limit efficacy , significant level GW recurrence associate local skin reaction . AP611074 synthetic new chemical entity potent selective inhibitor interaction two viral protein HPV6 HPV11 , interaction necessary step HPV DNA replication thus viral production . AP611074 `` first class '' specific HPV antiviral describe treat condyloma cause HPV infection .</detailed_description>
	<mesh_term>Warts</mesh_term>
	<mesh_term>Papillomavirus Infections</mesh_term>
	<mesh_term>Antiviral Agents</mesh_term>
	<criteria>Main Male female patient age 18 55 year . External condylomas , 115 lesion , nonconfluent individually isolate . Lesions must internal ( ie , must penetrate urethral meatus , vagina anal canal ) ; visualization must complete patient investigator without major facilitation maneuver easily document digital picture . Lesions total surface small 5 cm2 , individual surface small 1 cm2 ; lesion easily measure use `` French Catheter Scale '' . Lesions treat appear 16 month screen patient receive previous condyloma treatment since appearance . For patient previous episode condyloma lesion , n't receive condyloma treatment least 12 month screen . Main Patients history presence cardiovascular , pulmonary , gastrointestinal , hepatic , renal , metabolic , hematological , neurologic , psychiatric , systemic infectious disease , Investigator 's judgment , prevent patient participate study . Patients VIN PIN ( intraepithelial neoplasia vulva penis ; ie , Bowenoid papulosis ) , genital disease ( ie , lichen sclerosus , lichen planus , lichen simplex chronicus , dermatitis , psoriasis , bullous disease , systemic disease genital manifestation ) require treatment . Patients fibroepithelial polyp scaly nonviral papilloma , seborrheic keratosis , follicular papule , syringoma , circumscribe lymphangioma . Patients whose skin condition coloration would interfere observation followup lesion study . Patients proper followup lesion study possible , hair growth treatment area .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Genital wart</keyword>
	<keyword>Anogenital wart</keyword>
	<keyword>HPV</keyword>
	<keyword>Human papillomavirus</keyword>
	<keyword>Antiviral</keyword>
</DOC>